[ad_1] PERFORMANCE ANALYSIS Endonovo Therapeutics (OTC: ENDV) IN FOCUS: Endonovo Therapeutics (OTC: ENDV) recorded -29.666667% compared to last month and recorded -57.8% in the last quarter. The stock showed a return of -99.296667% over five years and recorded a weekly return of 5.5%. The stock was seen with a return …
Read More »